Oxidative stress as a potential biomarker for determining disease activity in patients with Rheumatoid Arthritis

References

• Filippin LI, Vercelino R, Marroni NP, Xavier RM. Redox signaling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008;152:415–422.
   PubMed Web of Science ®Google Scholar
• Mirshafiey A, Mohsenzadegan M. The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J Allergy Asthma Immunol 2008;7:195–202.
   PubMed Web of Science ®Google Scholar
• Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology(Oxford). 2012 [Epub ahead of print].
   Google Scholar
• Gringhuis SI, Leow A, Papendrecht-Van Der Voort EA, Remans PH, Breedveld FC, Verweij CL. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 2000;164:2170–2179.
   PubMed Web of Science ®Google Scholar
• Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, . Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther 2011;13:R121.
   Google Scholar
• Vaya J. Exogenous markers for the characterization of human diseases associated with oxidative stress. Biochimie 2012 (in press).
   Google Scholar
• Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, El-Sorougy IM, Abdou MS. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 2011;14: 325–331.
   PubMed Web of Science ®Google Scholar
• Kundu S, Bala A, Ghosh P, Mukhopadhyay D, Mitra A, Sarkar A, . Attenuation of oxidative stress by allylpyrocatechol in synovial cellular infiltrate of patients with Rheumatoid Arthritis. Free Radical Res 2011;45:518–526.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–324.
   PubMed Web of Science ®Google Scholar
• van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 2011;63: 37–42.
   PubMed Web of Science ®Google Scholar
• van der Heijde DM, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, . Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49: 916–920.
   PubMed Web of Science ®Google Scholar
• van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845–1850.
   PubMed Web of Science ®Google Scholar
• Markert M, Andrews PC, Babior BM. Measurement of O2− production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods in Enzymol 1984;105:358–365.
   PubMed Web of Science ®Google Scholar
• Dong J, Chen P, Wang R, Yu D, Zhang Y, Xiao W. NADPH oxidase: a target for the modulation of the excessive oxidase damage induced by overtraining in rat neutrophils. Int J Biol Sci 2011;7:881–891.
   Google Scholar
• Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003;278:3170–3175.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Saha P, Mandal G, Mukhopadhyay D, Roy S, Singh SK, . Monitoring of intracellular nitric oxide in Leishmaniasis: its applicability in patients with visceral leishmaniasis. Cytometry Part A 2011;79:35–45.
   PubMedGoogle Scholar
• Grootveld M, Henderson EB, Farrell A, Blake DR, Parkes HG, Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J 1991;273:459–467.
   Google Scholar
• McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974;185: 529–531.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4th edn. New York: Oxford University Press; 2000. pp. 130–131.
   Google Scholar
• Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265–278.
   PubMed Web of Science ®Google Scholar
• Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 1995;339:73–89.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030–3034.
   PubMed Web of Science ®Google Scholar
• Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002;30:620–650.
   PubMed Web of Science ®Google Scholar
• Mantle D, Falkous G, Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999;284:45–58.
   PubMed Web of Science ®Google Scholar
• Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V. Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients. Dis Markers 2009;26:41–48.
   PubMed Web of Science ®Google Scholar
• Hirao M, Yamasaki N, Oze H, Ebina K, Nampei A, Kawato Y, . Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab. Rheumatol Int 2011 (in press).
   PubMedGoogle Scholar